21 - 23 out of 23Page size: 10
  1. 2025

  2. Adjunct EF-M2 therapy improves clinical activity, steroid-sparing, and macrophage-linked biomarkers in feline chronic enteropathy: A randomized, double-blind, and placebo-controlled trial

    Pokushalov, E., Garcia, C., Smith, J., Kudlay, D., Revkov, N., Shcherbakova, A., Johnson, M. & Miller, R., Dec 2025, In: Veterinary World. 18, 12, p. 3914-3928 15 p.

    Research output: Contribution to journal › Article › peer-review

  3. Precision Glyco-Modulation of Macrophages with EF-M2 (ImmutalonTM) Improves Function and Lowers Inflammatory Biomarkers in Aging Dogs: A Double-Blind, Placebo-Controlled Trial

    Pokushalov, E., Kudlay, D., Garcia, C., Smith, J., Revkov, N., Shcherbakova, A. & Miller, R., 9 Dec 2025, In: Veterinary Sciences. 12, 12, 16 p., 1168.

    Research output: Contribution to journal › Article › peer-review

  4. Design and Biological Evaluation of Monoterpene-Conjugated (S)-2-Ethoxy-3-(4-(4-hydroxyphenethoxy)phenyl)propanoic Acids as New Dual PPARα/γ Agonists

    Borisov, S. A., Blokhin, M. E., Meshkova, Y. V., Marenina, M. K., Zhukova, N. A., Pavlova, S. V., Lastovka, A. V., Fomenko, V. V., Zhurakovsky, I. P., Luzina, O. A., Khvostov, M. V., Kudlay, D. A. & Salakhutdinov, N. F., 14 Dec 2025, In: Molecules. 30, 24, 23 p., 4775.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 Next

ID: 65414320